Dr. Durr completed his medical school and residency in Ophthalmology at the Université de Montréal. He pursued his training in glaucoma and advanced anterior segment surgery (GAASS) for two years at the University of Toronto under Dr. Ike Ahmed. He currently practices at the Centre Hospitalier de l’Université de Montréal (CHUM) where he treats a variety of glaucoma pathologies, cataracts and complex anterior segment reconstruction.
His research activities touch upon novelties in glaucoma and cataract surgery. Currently, Dr. Durr has several ongoing projects on minimally invasive glaucoma surgery and novel intraocular lenses. He has published numerous articles and two book chapters. At the University, Dr. Durr teaches medical students, residents and clinical fellows. He is the current glaucoma fellowship program director.
Financial disclosure: Dr. Durr has/had an affiliation (financial or otherwise) with a commercial organization:
- Alcon Laboratories
- Allergan, Inc.
- Avisi Technologies Inc.
- Bausch + Lomb
- Glaukos
- Ivantis, Inc.
- Johnson & Johnson Vision
- Nova Eye MD, Inc.
- Santen, Inc.
Sessions in which Georges Durr participates
Friday 25 June, 2021
Access the Live Meeting: https://www.yourconference.live/COSHow to tackle anterior capsular plaques
Sunday 27 June, 2021
What if we could go back in time in glaucoma management? What would you do differently?Learning ObjectivesAt the end of this symposium, participants will be able to:Recognize the importance of setting IOP targets in patients with glaucomaExplain how to monitor progression through VF, OCT changes and other toolsIdentify adherence issues in patients and when to refer patients for surgical interventionsDiscuss the ti...
